Skip to main content

GE Healthcare to Acquire Applied Precision

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has inked an agreement to acquire cellular imaging products firm Applied Precision for an undisclosed sum.

Applied Precision's products, which include high-resolution and super-resolution microscopy instruments, are expected to complement GE Healthcare's In Cell analyzers that are used for high-throughput sub-cellular analysis in cell biology research.

GE Healthcare said that it will retain Applied Precision's facility in Issaquah, Wash.

"The worldwide resources of GE Healthcare will allow us to significantly widen our reach into new markets and provide a stronger support network for our existing customers," Applied Precision CEO Joe Victor said in a statement.

The firms expect to close the deal in the second quarter of this year.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.